Man Group plc Makes New Investment in Humana Inc. $HUM

Man Group plc acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 33,467 shares of the insurance provider’s stock, valued at approximately $13,294,000.

Several other hedge funds also recently bought and sold shares of HUM. Manning & Napier Advisors LLC bought a new position in Humana in the second quarter worth approximately $1,412,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares during the period. Sustainable Insight Capital Management LLC grew its position in shares of Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after buying an additional 4,740 shares in the last quarter. Pzena Investment Management LLC bought a new position in shares of Humana during the 2nd quarter worth $1,749,014,000. Finally, Swedbank AB increased its stake in shares of Humana by 6.2% during the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock valued at $28,636,000 after buying an additional 6,534 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research reports. UBS Group started coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective on the stock in a report on Thursday, July 30th. Sanford C. Bernstein restated an “outperform” rating and set a $425.00 target price on shares of Humana in a report on Wednesday, June 3rd. JPMorgan Chase & Co. lifted their price target on Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a report on Monday, August 10th. Finally, HSBC lowered shares of Humana to a “hold” rating in a research note on Thursday, July 30th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $403.91.

Humana Trading Up 0.4%

NYSE HUM opened at $392.72 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market capitalization of $47.16 billion, a PE ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72. The company has a fifty day moving average of $385.08 and a 200 day moving average of $287.78.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period last year, the business earned $6.27 earnings per share. Research analysts forecast that Humana Inc. will post 9.12 earnings per share for the current year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.